Research programme: pentavalent meningococcal vaccine conjugate - PATH/ Serum Institute of India

Drug Profile

Research programme: pentavalent meningococcal vaccine conjugate - PATH/ Serum Institute of India

Alternative Names: Meningococcal vaccine groups A,C,W-135, Y, X conjugate - PATH; Polyvalent meningitis vaccine - PATH; Thermostable pentavalent conjugate meningococcal vaccine - PATH

Latest Information Update: 19 Oct 2016

Price : $50

At a glance

  • Originator PATH; Serum Institute of India
  • Class Meningococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Research Meningococcal infections

Most Recent Events

  • 18 Oct 2016 Early research in Meningococcal infections (Prevention) in India before October 2016 (Serum Institute of India pipeline, October 2016)
  • 13 Apr 2016 Development is ongoing in the US
  • 31 Oct 2013 Development of this pentavalent meningococcal vaccine conjugate is ongoing with PATH
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top